Quantitative analysis of the interactions between HIV-1 integrase and retroviral reverse transcriptases

Biochemical Journal

Volumn 412, Issue 1, 2008, Pages 163-170

  Herschhorn, Alon ^a   Oz Gleenberg, Iris ^a   Hizi, Amnon ^a  

^a TEL AVIV UNIVERSITY   (Israel)

Author keywords

HIV 1; Integrase (IN); Physical interactions; Reverse transcriptase (RT); Surface plasmon resonance (SPR)

Indexed keywords

BINDING SITES; CHEMICAL ANALYSIS; PROTEINS; SURFACE PLASMON RESONANCE; VIRUSES;

LEUKAEMIA VIRUS; PHYSICAL INTERACTIONS; REVERSE TRANSCRIPTASE (RT);

ENZYME ACTIVITY;

INTEGRASE; RNA DIRECTED DNA POLYMERASE;

ARTICLE; BINDING SITE; COMPLEX FORMATION; CONFORMATIONAL TRANSITION; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME BINDING; ENZYME INHIBITION; ENZYME KINETICS; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 2; MURINE LEUKEMIA VIRUS; NONHUMAN; PRIORITY JOURNAL; PROTEIN INTERACTION; QUANTITATIVE ANALYSIS; RETROVIRUS; SURFACE PLASMON RESONANCE;

DNA, SINGLE-STRANDED; ENZYMES, IMMOBILIZED; HIV INTEGRASE; HIV REVERSE TRANSCRIPTASE; KINETICS; LEUKEMIA VIRUS, MURINE; MODELS, BIOLOGICAL; PROTEIN BINDING; RETROVIRIDAE PROTEINS; RNA-DIRECTED DNA POLYMERASE; SUBSTRATE SPECIFICITY;

HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 2; MURINAE;

EID: 43549095213     PISSN: 02646021     EISSN: None     Source Type: Journal    
DOI: 10.1042/BJ20071279     Document Type: Article

References (51)

1. Coffin, J. M., Hughes, S. H. and Varmus, H. E. (1997) Retroviruses, Cold Spring Harbor Laboratory Press, New York
2. Skalka, A. M. and Goff, S. P. (1993) Reverse Transcriptase, Cold Spring, Harbor Laboratory Press, Cold Spring Harbor, New York
3. Asante-Appiah, E. and Skalka, A. M. (1999) HIV-1 integrase: structural organization, conformational changes, and catalysis. Adv. Virus Res. 52, 351-369
4. Chiu, T. K. and Davies, D. R. (2004) Structure and function of HIV-1 integrase. Curr. Top. Med. Chem. 4, 965-977
5. Craigie, R. (2002) In Retroviral DNA Integration (Craig, N. L., Craigie, R., Gellert, M. and Lambowitz, M., eds), pp. 613-630, American Society for Microbiology, Washington, D.C.
6. Vandegraaff, N. and Engelman, A. (2007) Molecular mechanisms of HIV integration and therapeutic intervention. Expert Rev. Mol. Med. 9, 1-19
7. Bukrinsky, M. I., Sharova, N., McDonald, T. L., Pushkarskaya, T., Tarpley, W. G. and Stevenson, M. (1993) Association of integrase, matrix, and reverse transcriptase antigens of human immunodeficiency virus type 1 with viral nucleic acids following acute infection. Proc. Natl. Acad. Sci. U.S.A. 90, 6125-6129
8. Bushman, F. D. and Miller, M. D. (1997) Tethering human immunodeficiency virus type 1 preintegration complexes to target DNA promotes integration at nearby sites. J. Virol. 71, 458-464
9. Farnet, C. M. and Bushman, F. D. (1997) HIV-1 cDNA integration: requirement of HMG I(Y) protein for function of preintegration complexes in vitro. Cell 88, 483-492
10. Fouchier, R. A. and Malim, M. H. (1999) Nuclear import of human immunodeficiency virus type-1 preintegration complexes. Adv. Virus Res. 52, 275-299
11. Hu, S. C., Court, D. L., Zweig, M. and Levin, J. G. (1986) Murine leukemia virus pol gene products: analysis with antisera generated against reverse transcriptase and endonuclease fusion proteins expressed in Escherichia coli. J. Virol. 60, 267-274
12. Oz Gleenberg, I., Avidan, O., Goldgur, Y., Herschhorn, A. and Hizi, A. (2005) Peptides derived from the reverse transcriptase of human immunodeficiency virus type 1 as novel inhibitors of the viral integrase. J. Biol. Chem. 280, 21987-21996
13. Oz, I., Avidan, O. and Hizi, A. (2002) Inhibition of the integrases of human immunodeficiency viruses type 1 and type 2 by reverse transcriptases. Biochem. J. 361, 557-566
14. Tasara, T., Maga, G., Hottiger, M. O. and Hubscher, U. (2001) HIV-1 reverse transcriptase and integrase enzymes physically interact and inhibit each other. FEBS Lett. 507, 39-44
15. Hehl, E. A., Joshi, P., Kalpana, G. V. and Prasad, V. R. (2004) Interaction between human immunodeficiency virus type 1 reverse transcriptase and integrase proteins. J. Virol. 78, 5056-5067
16. Zawahir, Z. and Neamati, N. (2006) Inhibition of HIV-1 integrase activity by synthetic peptides derived from the HIV-1 HXB2 Pol region of the viral genome. Bioorg. Med. Chem. Lett. 16, 5199-5202
17. Harris, D. and Engelman, A. (2000) Both the structure and DNA binding function of the barrier-to-autointegration factor contribute to reconstitution of HIV type 1 integration in vitro. J. Biol. Chem. 275, 39671-39677
18. Hindmarsh, P., Ridky, T., Reeves, R., Andrake, M., Skalka, A. M. and Leis, J. (1999) HMG protein family members stimulate human immunodeficiency virus type 1 and avian sarcoma virus concerted DNA integration in vitro. J. Virol. 73, 2994-3003
19. Kalpana, G. V., Marmon, S., Wang, W., Crabtree, G. R. and Goff, S. P. (1994) Binding and stimulation of HIV-1 integrase by a human homolog of yeast transcription factor SNF5. Science 266, 2002-2006
20. Lee, M. S. and Craigie, R. (1998) A previously unidentified host protein protects retroviral DNA from autointegration. Proc. Natl. Acad. Sci. U.S.A. 95, 1528-1533
21. Zheng, R., Ghirlando, R., Lee, M. S., Mizuuchi, K., Krause, M. and Craigie, R. (2000) Barrier-to-autointegration factor (BAF) bridges DNA in a discrete, higher-order nucleoprotein complex. Proc. Natl. Acad. Sci. U.S.A. 97, 8997-9002
22. Oz Gleenberg, I., Herschhorn, A., Goldgur, Y. and Hizi, A. (2007) Inhibition of human immunodeficiency virus type-1 reverse transcriptase by a novel peptide derived from the viral integrase. Arch. Biochem. Biophys. 458, 202-212
23. Dobard, C. W., Briones, M. S. and Chow, S. A. (2007) Molecular mechanisms by which HIV-1 integrase stimulates the early steps of reverse transcription. J. Virol. 81, 10037-10046
24. Barsov, E. V., Huber, W. E., Marcotrigiano, J., Clark, P. K., Clark, A. D., Arnold, E. and Hughes, S. H. (1996) Inhibition of human immunodeficiency virus type 1 integrase by the Fab fragment of a specific monoclonal antibody suggests that different multimerization states are required for different enzymatic functions. J. Virol. 70, 4484-4494
25. Sevilya, Z., Loya, S., Hughes, S. H. and Hizi, A. (2001) The ribonuclease H activity of the reverse transcriptases of human immunodeficiency viruses type 1 and type 2 is affected by the thumb subdomain of the small protein subunits. J. Mol. Biol. 311, 957-971
26. Hizi, A., Tal, R. and Hughes, S. H. (1991) Mutational analysis of the DNA polymerase and ribonuclease H activities of human immunodeficiency virus type 2 reverse transcriptase expressed in Escherichia coli. Virology 180, 339-346
27. Avidan, O., Meer, M. E., Oz, I. and Hizi, A. (2002) The processivity and fidelity of DNA synthesis exhibited by the reverse transcriptase of bovine leukemia virus. Eur. J. Biochem. 269, 859-867
28. Roden, L. D. and Myszka, D. G. (1996) Global analysis of a macromolecular interaction measured on BIAcore. Biochem. Biophys. Res. Commun. 225, 1073-1077
29. Stenberg, E., Persson, B., Roos, H. and Urbaniczky, C. (1991) Quantitative determination of surface concentration of protein with surface plasmon resonance using radiolabeled proteins. J. Colloid Interface Sci. 143, 513-526
30. Hindmarsh, P. and Leis, J. (1999) Retroviral DNA integration. Microbiol. Mol. Biol. Rev. 63, 836-843
31. Loya, S., Bakhanashvili, M., Kashman, Y. and Hizi, A. (1995) Mechanism of inhibition of HIV reverse transcriptase by toxiusol, a novel general inhibitor of retroviral and cellular DNA polymerases. Biochemistry 34, 2260-2266
32. Herschhorn, A., Oz-Gleenberg, I. and Hizi, A. (2008) Mechanism of inhibition of HIV-1 reverse transcriptase by the novel broad-range DNA polymerase inhibitor N-{2-[4-(Aminosulfonyl)phenyl]ethyl}-2-(2-thienyl) acetamide. Biochemistry 47, 490-502
33. Wang, L. Z., Kenyon, G. L. and Johnson, K. A. (2004) Novel mechanism of inhibition of HIV-1 reverse transcriptase by a new non-nucleoside analog, KM-1. J. Biol. Chem. 279, 38424-38432
34. Myszka, D. G. (2000) Kinetic, equilibrium, and thermodynamic analysis of macromolecular interactions with BIAcore. Methods Enzymol. 323, 325-340
35. Reference deleted
36. Karlsson, R. and Falt, A. (1997) Experimental design for kinetic analysis of protein-protein interactions with surface plasmon resonance biosensors. J. Immunol. Methods 200, 121-133
37. Miller, M. D., Farnet, C. M. and Bushman, F. D. (1997) Human immunodeficiency virus type 1 preintegration complexes: studies of organization and composition. J. Virol. 71, 5382-5390
38. Ciuffi, A. and Bushman, F. D. (2006) Retroviral DNA integration: HIV and the role of LEDGF/p75. Trends Genet. 22, 388-395
39. Van Maele, B., Busschots, K., Vandekerckhove, L., Christ, F. and Debyser, Z. (2006) Cellular co-factors of HIV-1 integration. Trends Biochem. Sci. 31, 98-105
40. Dayam, R., Deng, J. and Neamati, N. (2006) HIV-1 integrase inhibitors: 2003-2004 update. Med. Res. Rev. 26, 271-309
41. Gordon, C. P., Griffith, R. and Keller, P. A. (2007) Control of HIV through the inhibition of HIV-1 integrase: a medicinal chemistry perspective. Med. Chem. 3, 199-220
42. Tarrago-Litvak, L., Andreola, M. L., Fournier, M., Nevinsky, G. A., Parissi, V., de Soultrait, V. R. and Litvak, S. (2002) Inhibitors of HIV-1 reverse transcriptase and integrase: classical and emerging therapeutical approaches. Curr. Pharm. Des. 8, 595-614
43. Evering, T. H. and Markowitz, M. (2007) Raltegravir (MK-0518): An integrase inhibitor for the treatment of HIV-1. Drugs Today 43, 865-877
44. de Soultrait, V. R., Desjobert, C. and Tarrago-Litvak, L. (2003) Peptides as new inhibitors of HIV-1 reverse transcriptase and integrase. Curr. Med. Chem. 10, 1765-1778
45. Hayouka, Z., Rosenbluh, J., Levin, A., Loya, S., Lebendiker, M., Veprintsev, D., Kotler, M., Hizi, A., Loyter, A. and Friedler, A. (2007) Inhibiting HIV-1 integrase by shifting its oligomerization equilibrium. Proc. Natl. Acad. Sci. U.S.A. 104, 8316-8321
46. Maroun, R. G., Gayet, S., Benleulmi, M. S., Porumb, H., Zargarian, L., Merad, H., Leh, H., Mouscadet, J. F., Troalen, F. and Fermandjian, S. (2001) Peptide inhibitors of HIV-1 integrase dissociate the enzyme oligomers. Biochemistry 40, 13840-13848
47. Puras Lutzke, R. A., Eppens, N. A., Weber, P. A., Houghten, R. A. and Plasterk, R. H. (1995) Identification of a hexapeptide inhibitor of the human immunodeficiency virus integrase protein by using a combinatorial chemical library. Proc. Natl. Acad. Sci. U.S.A. 92, 11456-11460
48. Gleenberg, I. O., Herschhorn, A. and Hizi, A. (2007) Inhibition of the activities of reverse transcriptase and integrase of human immunodeficiency virus type-1 by peptides derived from the homologous viral protein R (Vpr). J. Mol. Biol. 369, 1230-1243
49. Rosenbluh, J., Hayouka, Z., Loya, S., Levin, A., Armon-Omer, A., Britan, E., Hizi, A., Kotler, M., Friedler, A. and Loyter, A. (2007) Interaction between HIV-1 Rev and integrase proteins: a basis for the development of anti-HIV peptides. J. Biol. Chem. 282, 15743-15753
50. Correll, T. and Klibanov, O. M. (2008) Integrase inhibitors: a new treatment option for patients with human immunodeficiency virus infection. Pharmacotherapy 28, 90-101
51. Murray, J. M., Emery, S., Kelleher, A. D., Law, M., Chen, J., Hazuda, D. J., Nguyen, B. Y., Teppler, H. and Cooper, D. A. (2007) Antiretroviral therapy with the integrase inhibitor raltegravir alters decay kinetics of HIV, significantly reducing the second phase. AIDS 21, 2315-2321